Search

everythinglearnresearchcommunity

for

Search:↓

Lower postoperative hematocrit levels increase the risk of death within 28 days after coronary artery bypass surgery.

The polyherbal hair dye is a safe, effective, and eco-friendly alternative to synthetic dyes.

Alopecia can be caused by multicentric reticulohistiocytosis.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Vitiligo patients have higher risks of autoimmune diseases, infections, and skin cancer.

Blood groups are not linked to hidradenitis suppurativa.

The natural hair dye is safe, effective, and good for scalp health.

The natural hair dye is safe, effective, and good for scalp health.

Off-label treatments are heavily used for alopecia areata due to limited approved options.

Female Pattern Hair Loss is linked to genetics, diet, stress, and certain health conditions.

Statins do not help improve alopecia areata.

Statins do not help improve alopecia areata.

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Severe COVID-19 increases the risk of hair loss.

Combining microneedling with 5% minoxidil is a safe and effective treatment for female pattern hair loss, promoting significant hair regrowth.

A holistic approach combining homeopathy, Xogen therapy, and lifestyle changes may improve hair loss.

Keratosis pilaris is common in young females, and dermoscopy helps diagnose it accurately.

Topical minoxidil can cause unwanted hair growth and eye issues, especially in infants, so better education and guidelines are needed.

Topical finasteride is well-tolerated and satisfies most users with minimal side effects.

Baricitinib is effective and safe for treating alopecia areata.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Baricitinib is effective and safe for treating severe alopecia areata.

FUE technique offers higher satisfaction and broader use for women needing hair transplants.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

Androgenetic alopecia doesn't increase the risk of heart-related health issues.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Exclamation-mark hairs and yellow dots indicate alopecia areata, while follicular ostia loss and white scarring indicate lichen planopilaris and discoid lupus erythematosus.

Ultraviolet techniques help identify Grover’s Disease, which may be underdiagnosed in young people and females.